Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study.

Mikkel Pejstrup Agger,Else Rubæk Danielsen,Marcus Schultz Carstensen,N Mai Nguyen,Maibritt Horning,Mark Alexander Henney, Christopher Boe Ravn Jensen,Anders Ohlhues Baandrup,Troels Wesenberg Kjær,Kristoffer Hougaard Madsen,Kamilla Miskowiak,Paul Michael Petersen,Peter Høgh

Journal of Alzheimer's disease : JAD（2023）

Cited 1|Views15
No score
Abstract
Treatment with 40 Hz ISF offers no significant safety or adherence concerns. Potential impact on secondary outcomes must be tested in larger scale clinical trials.
More
Translated text
Key words
40 Hz,Alzheimer’s disease,gamma entrainment,invisible spectral flicker,light-based neurostimulation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined